American Century Companies Inc. Acquires New Position in Phreesia, Inc. (NYSE:PHR)

American Century Companies Inc. bought a new position in shares of Phreesia, Inc. (NYSE:PHR - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 25,598 shares of the company's stock, valued at approximately $644,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. State Street Corp raised its stake in Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company's stock valued at $30,256,000 after purchasing an additional 88,517 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Phreesia by 10.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock worth $12,415,000 after purchasing an additional 46,209 shares in the last quarter. Wesbanco Bank Inc. increased its position in shares of Phreesia by 76.9% during the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company's stock valued at $1,157,000 after purchasing an additional 20,000 shares during the last quarter. Barclays PLC raised its holdings in shares of Phreesia by 83.6% during the 3rd quarter. Barclays PLC now owns 94,929 shares of the company's stock valued at $2,163,000 after buying an additional 43,225 shares in the last quarter. Finally, Franklin Resources Inc. lifted its position in Phreesia by 3.0% in the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company's stock worth $31,495,000 after buying an additional 42,973 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company's stock.

Phreesia Stock Down 3.1 %

Shares of PHR stock traded down $0.74 during midday trading on Thursday, reaching $23.16. 52,647 shares of the stock were exchanged, compared to its average volume of 473,531. The firm has a market cap of $1.36 billion, a PE ratio of -15.78 and a beta of 0.82. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The company's 50 day moving average is $26.27 and its two-hundred day moving average is $24.28. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $30.53.

Insider Buying and Selling

In other news, General Counsel Allison C. Hoffman sold 8,426 shares of the company's stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $27.31, for a total value of $230,114.06. Following the sale, the general counsel now directly owns 146,126 shares of the company's stock, valued at $3,990,701.06. This represents a 5.45 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Balaji Gandhi sold 5,827 shares of the stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $27.31, for a total transaction of $159,135.37. Following the completion of the transaction, the chief financial officer now owns 141,846 shares of the company's stock, valued at approximately $3,873,814.26. The trade was a 3.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 168,791 shares of company stock valued at $4,700,424 over the last ninety days. Company insiders own 5.80% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on PHR shares. DA Davidson lowered their price objective on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a report on Monday. Canaccord Genuity Group lifted their price objective on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday, March 13th. Citigroup raised their price target on Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a research report on Friday, January 10th. Piper Sandler reaffirmed an "overweight" rating and issued a $33.00 target price (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Finally, Royal Bank of Canada raised shares of Phreesia from a "sector perform" rating to an "outperform" rating and increased their price target for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Phreesia currently has an average rating of "Buy" and a consensus target price of $31.33.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.